The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Anti-Inflammatory Applications of Melittin, a Major Component of Bee Venom: Detailed Mechanism of Action and Adverse Effects
Open accessAbstract
Inflammation is a pervasive phenomenon triggered by the innate and adaptive immune systems to maintain homeostasis. The phenomenon normally leads to recovery from infection and healing, but when not properly phased, inflammation may cause immune disorders. Bee venom is a toxin that bees use for their protection from enemies. However, for centuries it has been used in the Orient as an anti-inflammatory medicine for the treatment of chronic inflammatory diseases. Bee venom and its major component, melittin, are potential means of reducing excessive immune responses and provide new alternatives for the control of inflammatory diseases. Recent experimental studies show that the biological functions of melittin could be applied for therapeutic use in vitro and in vivo. Reports verifying the therapeutic effects of melittin are accumulating in the literature, but the cellular mechanism(s) of the anti-inflammatory effects of melittin are not fully elucidated. In the present study, we review the current knowledge on the therapeutic effects of melittin and its detailed mechanisms of action against several inflammatory diseases including skin inflammation, neuroinflammation, atherosclerosis, arthritis and liver inflammation, its adverse effects as well as future prospects regarding the use of melittin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Points of control in inflammation
Nathan, C. (2002) · Nature · doi:10.1038/nature01320 · Cited by 2,738
Atherosclerosis is an inflammatory disease
Ross, R. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70266-8 · Cited by 1,451
Bee and Wasp Venoms: The biochemistry and pharmacology of their peptides and enzymes are reviewed.
Habermann, E. (1972) · Science · doi:10.1126/science.177.4046.314 · Cited by 1,324
The actions of melittin on membranes
Dempsey, C. E. (1990) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(90)90006-x · Cited by 848
To be, or not to be: NF-κB is the answer – role of Rel/NF-κB in the regulation of apoptosis
Kucharczak, J., Simmons, M. J., Fan, Y., & Gélinas, C. (2003) · Oncogene · doi:10.1038/sj.onc.1207230 · Cited by 769
A comprehensive review of amyotrophic lateral sclerosis
Zarei, S., Carr, K., Reiley, L., Diaz, K., Guerra, O., Altamirano, P., Pagani, W., Lodin, D., Orozco, G., & Chinea, A. (2015) · Surgical Neurology International · doi:10.4103/2152-7806.169561 · Cited by 709
Melittin: a Membrane-active Peptide with Diverse Functions
Raghuraman, H., & Chattopadhyay, A. (2007) · Bioscience Reports · doi:10.1007/s10540-006-9030-z · Cited by 651
SON, D., LEE, J., LEE, Y., SONG, H., LEE, C., & HONG, J. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.04.004 · Cited by 633
Molecular mechanism of antimicrobial peptides: The origin of cooperativity
Huang, H. W. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.02.001 · Cited by 471
Moreno, M., & Giralt, E. (2015) · Toxins · doi:10.3390/toxins7041126 · Cited by 375
Vowels, B. R., Yang, S., & Leyden, J. J. (1995) · Infection and Immunity · doi:10.1128/iai.63.8.3158-3165.1995 · Cited by 330
Anti-Inflammatory Treatments for Chronic Diseases: A Review
Laveti, D., Kumar, M., Hemalatha, R., Sistla, R., Naidu, V., Talla, V., Verma, V., Kaur, N., & Nagpal, R. (2013) · Inflammation & Allergy-Drug Targets · doi:10.2174/18715281113129990053 · Cited by 325
Soman, N. R., Baldwin, S. L., Hu, G., Marsh, J. N., Lanza, G. M., Heuser, J. E., Arbeit, J. M., Wickline, S. A., & Schlesinger, P. H. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38842 · Cited by 293
Kim, J. (2005) · Dermatology · doi:10.1159/000087011 · Cited by 282
Kinetics and mechanism of hemolysis induced by melittin and by a synthetic melittin analogue
DeGrado, W. F., Musso, G. F., Lieber, M., Kaiser, E. T., & Kézdy, F. J. (1982) · Biophysical Journal · doi:10.1016/s0006-3495(82)84681-x · Cited by 266
Tosteson, M. T., Holmes, S. J., Razin, M., & Tosteson, D. C. (1985) · The Journal of Membrane Biology · doi:10.1007/bf01870697 · Cited by 251
Park, H. J., Lee, S. H., Son, D. J., Oh, K. W., Kim, K. H., Song, H. S., Kim, G. J., Oh, G. T., Yoon, D. Y., & Hong, J. T. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20626 · Cited by 251
Pamukcu, B., Lip, G. Y. H., & Shantsila, E. (2011) · Thrombosis Research · doi:10.1016/j.thromres.2011.03.025 · Cited by 218
Dissection of Antibacterial and Toxic Activity of Melittin
Asthana, N., Yadav, S. P., & Ghosh, J. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408881200 · Cited by 216
On the Mechanism of Pore Formation by Melittin
van den Bogaart, G., Guzmán, J. V., Mika, J. T., & Poolman, B. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805171200 · Cited by 213
Jang, M.-H., Shin, M.-C., Lim, S., Han, S., Park, H., Shin, I., Lee, J., Kim, K., Kim, E., & Kim, C. (2003) · Journal of Pharmacological Sciences · doi:10.1254/jphs.91.95 · Cited by 161
Moon, D., Park, S.-Y., Lee, K., Heo, M., Kim, K.-C., Kim, M.-O., Lee, J.-D., Choi, Y. H., & Kim, G. (2007) · International Immunopharmacology · doi:10.1016/j.intimp.2007.04.005 · Cited by 150
Moon, D., Park, S.-Y., Heo, M., Kim, K.-C., Park, C., Ko, W. S., Choi, Y. H., & Kim, G. (2006) · International Immunopharmacology · doi:10.1016/j.intimp.2006.07.027 · Cited by 148
Sobotka, A. K., Franklin, R. M., Adkinson, N. F., Valentine, M. D., Baer, H., & Lichtenstein, L. M. (1976) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(76)90076-2 · Cited by 144
Possible mechanisms of action of cobra snake venom cardiotoxins and bee venom melittin
Fletcher, J. E., & Jiang, M.-S. (1993) · Toxicon · doi:10.1016/0041-0101(93)90375-s · Cited by 142
The evolving role of Propionibacterium acnes in acne
Leyden, J. J. (2001) · Seminars in Cutaneous Medicine and Surgery · doi:10.1053/sder.2001.28207 · Cited by 122
Park, H. J., Lee, H., Choi, M. S., Son, D. J., Song, H. S., Song, M. J., Lee, J. M., Han, S., Kim, Y., & Hong, J. T. (2008) · Journal of Inflammation · doi:10.1186/1476-9255-5-7 · Cited by 114
Park, H. J., Son, D. J., Lee, C. W., Choi, M. S., Lee, U. S., Song, H. S., Lee, J. M., & Hong, J. T. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.09.023 · Cited by 107
Cytolytic peptide nanoparticles (‘NanoBees’) for cancer therapy
Pan, H., Soman, N. R., Schlesinger, P. H., Lanza, G. M., & Wickline, S. A. (2011) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.126 · Cited by 104
Bee Venom Phospholipase A2: Yesterday’s Enemy Becomes Today’s Friend
Lee, G., & Bae, H. (2016) · Toxins · doi:10.3390/toxins8020048 · Cited by 102
Self-citationProtective effect of melittin on inflammation and apoptosis in acute liver failure
Park, J., Kim, K. H., Lee, W., Han, S., & Park, K. (2011) · APOPTOSIS · doi:10.1007/s10495-011-0659-0 · Cited by 97
Subbalakshmi, C., Nagaraj, R., & Sitaram, N. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00328-2 · Cited by 93
Gajski, G., Domijan, A., Žegura, B., Štern, A., Gerić, M., Jovanović, I. N., Vrhovac, I., Madunić, J., Breljak, D., Filipič, M., et al. (2015) · Toxicon · doi:10.1016/j.toxicon.2015.12.005 · Cited by 91
A role for peptides in overcoming endosomal entrapment in siRNA delivery — A focus on melittin
Hou, K. K., Pan, H., Schlesinger, P. H., & Wickline, S. A. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.05.005 · Cited by 86
Huh, J., Baek, Y.-H., Lee, M., Choi, D., Park, D., & Lee, J.-D. (2010) · Cancer Letters · doi:10.1016/j.canlet.2009.11.013 · Cited by 84
Melittin restores proteasome function in an animal model of ALS
Yang, E. J., Kim, S. H., Yang, S. C., Lee, S. M., & Choi, S. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-69 · Cited by 82
Gajski, G., & Garaj‐Vrhovac, V. (2009) · International Journal of Toxicology · doi:10.1177/1091581809335051 · Cited by 71
Hu, H., Chen, D., Li, Y., & Zhang, X. (2005) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.58.1.0010 · Cited by 71
Park, J., Kum, Y., Lee, T.-I., Kim, S.-J., Lee, W., Kim, B., Kim, H.-S., Kim, K. H., & Park, K. (2011) · Experimental Biology and Medicine · doi:10.1258/ebm.2011.011127 · Cited by 70
Choi, M. S., Park, S., Choi, T., Lee, G., Haam, K.-K., Hong, M., Min, B.-I., & Bae, H. (2012) · Cytokine · doi:10.1016/j.cyto.2012.10.005 · Cited by 63
Self-citationEmerging drugs for the treatment of acne
Aslam, I., Fleischer, A. B., & Feldman, S. R. (2014) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2015.990373 · Cited by 62
Dual secured nano-melittin for the safe and effective eradication of cancer cells
Cheng, B., Thapa, B., Remant, K. C. B., & Xu, P. (2014) · Journal of Materials Chemistry B · doi:10.1039/c4tb01401d · Cited by 61
Melittin: An allergen of honeybee venom
Paull, B. R., Yunginger, J. W., & Gleich, G. J. (1977) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(77)90056-2 · Cited by 59
Han, S. M., Kim, J. M., Park, K. K., Chang, Y., & Pak, S. C. (2014) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-14-286 · Cited by 59
Biosynthesis of Melittin, a Toxic Peptide from Bee Venom
Kreil, G., & Bachmayer, H. (1971) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1971.tb01400.x · Cited by 50
Bee venom suppresses LPS-mediated NO/iNOS induction through inhibition of PKC-α expression
Lee, K.-G., Cho, H.-J., Bae, Y., Park, K., Choe, J., Chung, I., Kim, M., Yeo, J., Park, K., Lee, Y., et al. (2009) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2009.02.044 · Cited by 48
Melittin Ameliorates the Inflammation of Organs in an Amyotrophic Lateral Sclerosis Animal Model
Lee, S. H., Choi, S.-M., & Yang, E. J. (2014) · Experimental Neurobiology · doi:10.5607/en.2014.23.1.86 · Cited by 30
Park, J., Lee, W., Kim, H.-S., Han, S., Chang, Y., & Park, K. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370214533880 · Cited by 28
Kim, K., Sung, H.-J., Lee, W., An, H., Kim, J., Pak, S. C., Han, S., & Park, K.-K. (2015) · Toxins · doi:10.3390/toxins7093372 · Cited by 22
Rayahin, J., Buhrman, J. S., & Gemeinhart, R. A. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.09.012 · Cited by 22
Pharmacological evaluation of bee venom and melittin
Dantas, C. G., Nunes, T. L. G. M., Nunes, T. L. G. M., da Paixão, A. O., Reis, F. P., Júnior, W. D. L., Cardoso, J. C., Gomes, M. Z., & Gramacho, K. P. (2014) · Revista Brasileira de Farmacognosia · doi:10.1590/0102-695x20142413365 · Cited by 20
Cited by
Antimicrobial Peptides: A New Hope in Biomedical and Pharmaceutical Fields
Moretta, A., Scieuzo, C., Petrone, A. M., Salvia, R., Manniello, M. D., Franco, A., Lucchetti, D., Vassallo, A., Vogel, H., Sgambato, A., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.668632 · Cited by 497
Insect Antimicrobial Peptides, a Mini Review
Wu, Q., Patočka, J., & Kuča, K. (2018) · Toxins · doi:10.3390/toxins10110461 · Cited by 481
Therapeutic Properties of Bioactive Compounds from Different Honeybee Products
Cornara, L., Biagi, M., Xiao, J., & Burlando, B. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00412 · Cited by 460
Review: Lessons Learned From Clinical Trials Using Antimicrobial Peptides (AMPs)
Dijksteel, G. S., Ulrich, M. M. W., Middelkoop, E., & Boekema, B. K. H. L. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.616979 · Cited by 428
Bee Venom: Overview of Main Compounds and Bioactivities for Therapeutic Interests
Wehbe, R., Frangieh, J., Rima, M., El Obeid, D., Sabatier, J.-M., & Fajloun, Z. (2019) · Molecules · doi:10.3390/molecules24162997 · Cited by 372
Metadata
- Authors
- Lee, G., & Bae, H.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2016-05-11
- Volume
- 21
- Issue
- 5
- Pages
- 616
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W2389104996
- Cited by
- 275
- References
- 52
- FWCI
- 7.49
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.